Bioaugmentation with a pyridine-degrading bacterium in a membrane bioreactor treating pharmaceutical wastewater
Donghui Wen(Peking University), Lüjun Chen(Tsinghua University), Ruilin Xiong(Sun Yat-sen University), Jing Zhang(Zhejiang Chinese Medical University), Rui Liu(Tsinghua University)
Cited by 55
Related Papers
Combination of oral STING agonist MSA-2 and anti-TGF-β/PD-L1 bispecific antibody YM101: a novel immune cocktail therapy for non-inflamed tumors
|Journal of Hematology & Oncology|2022|178
TRIM38 inhibits TNFα- and IL-1β–triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3
|Proceedings of the National Academy of Sciences|2014|151
Induced phase separation of mutant NF2 imprisons the cGAS-STING machinery to abrogate antitumor immunity
|Molecular Cell|2021|128
Single cell profiling of primary and paired metastatic lymph node tumors in breast cancer patients
|Nature Communications|2022|109
Divergent Total Syntheses of (−)‐Daphnilongeranin B and (−)‐Daphenylline
|Angewandte Chemie International Edition|2017|98